**3. Results and Discussion**

The discovery of multi drug-resistant fungal pathogens increases the risk of medical complications whilst simultaneously limiting therapeutic options. The presented work is focused on the design and development of novel antifungal hydrogels for improvement of therapeutic efficacy of antifungal drugs such as thymoquinone, ocimene, and miramistin and compared to conventional drugs such as amphotericin B.
